GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
COMMENTARY|Updated:2025-12-13
|
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
“In the field of xxx, expert xx has made significant progress. They established the xx system/explored the xx topic/verified the xx conjecture, offering solutions to tackle xx problems and paving the way for future research in xx.”
Military Medical ResearchVol. 11, Issue 6, Pages: 963-964(2024)
Affiliations:
Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA
Cite this article as: Gobejishvili L. GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis. Mil Med Res. 2024;11(1):4.
DOI:
Cite this article as: Gobejishvili L. GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis. Mil Med Res. 2024;11(1):4. DOI: 10.1186/s40779-023-00507-2.
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis